Cargando…
β‐Adrenergic signaling in skin cancer
Activation of the sympathetic nervous system releases catecholamines that can interact with β‐adrenergic receptors on tumor cells. Preclinical models have shown that the signaling processes initiated by activation of β‐adrenergic receptors increase tumorigenesis, stimulate cell proliferation, and in...
Autores principales: | Batalla‐Covello, Jennifer, Ali, Shahrukh, Xie, Tongxin, Amit, Moran |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8984090/ https://www.ncbi.nlm.nih.gov/pubmed/35415461 http://dx.doi.org/10.1096/fba.2021-00097 |
Ejemplares similares
-
β-Adrenergic Receptor Signaling in Prostate Cancer
por: Braadland, Peder Rustøen, et al.
Publicado: (2015) -
Neurobiology of Cancer: The Role of β-Adrenergic Receptor Signaling in Various Tumor Environments
por: Mravec, Boris, et al.
Publicado: (2020) -
Nerve Density and Neuronal Biomarkers in Cancer
por: Ali, Shahrukh R., et al.
Publicado: (2022) -
β-Adrenergic receptor signaling in cardiac function and heart failure
por: Madamanchi, Aasakiran
Publicado: (2007) -
Concise Review: Neural Stem Cell‐Mediated Targeted Cancer Therapies
por: Mooney, Rachael, et al.
Publicado: (2018)